| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.32e-04 | 8 | 44 | 2 | GO:0098882 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.39e-05 | 3 | 45 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 2.78e-05 | 4 | 45 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DOCK10 ENAM DACT1 ROBO2 CSNK1A1L ARHGAP35 MAP7 TECTA ARHGEF26 CSNK1A1 WDR47 | 3.83e-05 | 1194 | 45 | 11 | GO:0000902 |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 4.63e-05 | 5 | 45 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 6.94e-05 | 6 | 45 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 1.78e-04 | 129 | 45 | 4 | GO:0039531 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 2.07e-04 | 10 | 45 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic pattern recognition receptor signaling pathway | 2.75e-04 | 58 | 45 | 3 | GO:0039532 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 2.63e-06 | 13 | 45 | 3 | GO:0030877 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RCOR1 ASXL2 CSNK1A1L LUC7L3 DDX21 POM121C SNRPB2 CSNK1A1 ARID2 ZNF541 CREBZF | 1.23e-04 | 1377 | 45 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.26e-04 | 8 | 45 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 4.06e-04 | 14 | 45 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | axon | 5.60e-04 | 891 | 45 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.11e-03 | 23 | 45 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | P-body | 1.38e-03 | 102 | 45 | 3 | GO:0000932 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 1.43e-03 | 26 | 45 | 2 | GO:0005847 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.66e-03 | 596 | 45 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | growth cone | 1.88e-03 | 245 | 45 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 2.03e-03 | 31 | 45 | 2 | GO:0005849 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.03e-03 | 31 | 45 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.11e-03 | 253 | 45 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.16e-03 | 32 | 45 | 2 | GO:0097470 | |
| GeneOntologyCellularComponent | U1 snRNP | 2.29e-03 | 33 | 45 | 2 | GO:0005685 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.64e-03 | 269 | 45 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 3.33e-03 | 287 | 45 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | cell cortex region | 4.23e-03 | 45 | 45 | 2 | GO:0099738 | |
| Domain | Znf_piccolo | 5.18e-06 | 2 | 43 | 2 | IPR008899 | |
| Domain | zf-piccolo | 5.18e-06 | 2 | 43 | 2 | PF05715 | |
| Domain | CTLH | 1.84e-04 | 9 | 43 | 2 | SM00668 | |
| Domain | CTLH_C | 2.30e-04 | 10 | 43 | 2 | IPR006595 | |
| Domain | CTLH | 2.30e-04 | 10 | 43 | 2 | PS50897 | |
| Domain | ELM2 | 3.97e-04 | 13 | 43 | 2 | SM01189 | |
| Domain | ELM2 | 3.97e-04 | 13 | 43 | 2 | PF01448 | |
| Domain | ELM2 | 3.97e-04 | 13 | 43 | 2 | PS51156 | |
| Domain | ELM2_dom | 3.97e-04 | 13 | 43 | 2 | IPR000949 | |
| Domain | SANT_dom | 1.62e-03 | 26 | 43 | 2 | IPR017884 | |
| Domain | LisH | 1.88e-03 | 28 | 43 | 2 | IPR006594 | |
| Domain | LisH | 1.88e-03 | 28 | 43 | 2 | SM00667 | |
| Domain | SANT | 1.88e-03 | 28 | 43 | 2 | PS51293 | |
| Domain | LISH | 1.88e-03 | 28 | 43 | 2 | PS50896 | |
| Domain | Myb_DNA-binding | 2.94e-03 | 35 | 43 | 2 | PF00249 | |
| Domain | ARM-like | 3.39e-03 | 270 | 43 | 4 | IPR011989 | |
| Domain | MYB_LIKE | 3.45e-03 | 38 | 43 | 2 | PS50090 | |
| Domain | Znf_FYVE_PHD | 4.68e-03 | 147 | 43 | 3 | IPR011011 | |
| Domain | SANT | 5.91e-03 | 50 | 43 | 2 | SM00717 | |
| Domain | SANT/Myb | 6.38e-03 | 52 | 43 | 2 | IPR001005 | |
| Pubmed | 2.30e-09 | 407 | 45 | 9 | 12693553 | ||
| Pubmed | MAPK8IP1 FKBP15 RCOR1 CSNK1A1L TCF20 BSN ARHGEF26 WDR26 CSNK1A1 WDR47 | 3.35e-07 | 963 | 45 | 10 | 28671696 | |
| Pubmed | SP1 RCOR1 ASXL2 TNRC6C MAP7 TCF20 PUM1 POM121C GARRE1 CNOT10 ARID2 | 1.52e-06 | 1429 | 45 | 11 | 35140242 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 1.64e-06 | 2 | 45 | 2 | 23403927 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 35695793 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23354688 | ||
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 1.64e-06 | 2 | 45 | 2 | 38852281 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 1.64e-06 | 2 | 45 | 2 | 26793095 | |
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 1.64e-06 | 2 | 45 | 2 | 9522121 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23690993 | ||
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 1.64e-06 | 2 | 45 | 2 | 25994086 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 27321892 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20332206 | ||
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 1.64e-06 | 2 | 45 | 2 | 37723657 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 32493491 | ||
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 1.64e-06 | 2 | 45 | 2 | 36929849 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 34216174 | ||
| Pubmed | Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling. | 1.64e-06 | 2 | 45 | 2 | 37108197 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 1.64e-06 | 2 | 45 | 2 | 21935939 | |
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 1.64e-06 | 2 | 45 | 2 | 36542875 | |
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 1.64e-06 | 2 | 45 | 2 | 25652077 | |
| Pubmed | 2.86e-06 | 486 | 45 | 7 | 20936779 | ||
| Pubmed | 3.60e-06 | 80 | 45 | 4 | 35803934 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.77e-06 | 1294 | 45 | 10 | 30804502 | |
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 4.91e-06 | 3 | 45 | 2 | 25242043 | |
| Pubmed | CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. | 4.91e-06 | 3 | 45 | 2 | 28878021 | |
| Pubmed | Type I Interferons Control Proliferation and Function of the Intestinal Epithelium. | 4.91e-06 | 3 | 45 | 2 | 26811327 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 28655862 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 19805514 | ||
| Pubmed | Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. | 4.91e-06 | 3 | 45 | 2 | 24616378 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 38147624 | ||
| Pubmed | FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning. | 9.81e-06 | 4 | 45 | 2 | 31338967 | |
| Pubmed | Cx43 phosphorylation sites regulate pancreatic cancer metastasis. | 9.81e-06 | 4 | 45 | 2 | 33603164 | |
| Pubmed | The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. | 9.81e-06 | 4 | 45 | 2 | 32728212 | |
| Pubmed | Regulation of p53-MDMX interaction by casein kinase 1 alpha. | 9.81e-06 | 4 | 45 | 2 | 16024788 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 30487124 | ||
| Pubmed | 1.29e-05 | 1139 | 45 | 9 | 36417873 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.44e-05 | 1155 | 45 | 9 | 20360068 | |
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 30651631 | ||
| Pubmed | Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. | 1.63e-05 | 5 | 45 | 2 | 30064974 | |
| Pubmed | A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. | 1.63e-05 | 5 | 45 | 2 | 23890787 | |
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 37944068 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 36989576 | ||
| Pubmed | Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer. | 1.63e-05 | 5 | 45 | 2 | 25628462 | |
| Pubmed | CKIα ablation highlights a critical role for p53 in invasiveness control. | 1.63e-05 | 5 | 45 | 2 | 21331045 | |
| Pubmed | 1.98e-05 | 655 | 45 | 7 | 35819319 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 15687492 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 14734538 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 19118383 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 19812333 | ||
| Pubmed | Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways. | 2.45e-05 | 6 | 45 | 2 | 11884395 | |
| Pubmed | Physiological role for casein kinase 1 in glutamatergic synaptic transmission. | 2.45e-05 | 6 | 45 | 2 | 16014721 | |
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 25636086 | ||
| Pubmed | MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling. | 2.45e-05 | 6 | 45 | 2 | 32511789 | |
| Pubmed | MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism. | 2.45e-05 | 6 | 45 | 2 | 33667384 | |
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 17686994 | ||
| Pubmed | Bifurcating action of Smoothened in Hedgehog signaling is mediated by Dlg5. | 3.42e-05 | 7 | 45 | 2 | 25644602 | |
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 25100735 | ||
| Pubmed | NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. | 3.42e-05 | 7 | 45 | 2 | 34615873 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 4.13e-05 | 1321 | 45 | 9 | 27173435 | |
| Pubmed | 4.54e-05 | 152 | 45 | 4 | 38360978 | ||
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 17244647 | ||
| Pubmed | Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. | 4.56e-05 | 8 | 45 | 2 | 17101137 | |
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 21930935 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 4.85e-05 | 754 | 45 | 7 | 33060197 | |
| Pubmed | Effects of Fam83h truncation mutation on enamel developmental defects in male C57/BL6J mice. | 5.86e-05 | 9 | 45 | 2 | 36272714 | |
| Pubmed | 5.86e-05 | 9 | 45 | 2 | 9601641 | ||
| Pubmed | 5.86e-05 | 9 | 45 | 2 | 21144999 | ||
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 21984185 | ||
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 25500533 | ||
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 31048766 | ||
| Pubmed | 8.22e-05 | 1116 | 45 | 8 | 31753913 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 8.39e-05 | 178 | 45 | 4 | 27637333 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 8.93e-05 | 351 | 45 | 5 | 38297188 | |
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 21984184 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 21709260 | ||
| Pubmed | Peli1 Modulates the Subcellular Localization and Activity of Mdmx. | 1.07e-04 | 12 | 45 | 2 | 29523541 | |
| Pubmed | Multiple roles of integrin-α3 at the neuromuscular junction. | 1.07e-04 | 12 | 45 | 2 | 28386022 | |
| Pubmed | 1.28e-04 | 75 | 45 | 3 | 29459360 | ||
| Pubmed | 1.38e-04 | 77 | 45 | 3 | 19505873 | ||
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 16452088 | ||
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 39183304 | ||
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 21228161 | ||
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 16600870 | ||
| Pubmed | 1.59e-04 | 210 | 45 | 4 | 16565220 | ||
| Pubmed | 1.65e-04 | 638 | 45 | 6 | 31182584 | ||
| Pubmed | 1.70e-04 | 15 | 45 | 2 | 31903119 | ||
| Pubmed | Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction. | 1.70e-04 | 15 | 45 | 2 | 18827223 | |
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 1.70e-04 | 15 | 45 | 2 | 21981923 | |
| Pubmed | 1.73e-04 | 83 | 45 | 3 | 28794006 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.84e-04 | 410 | 45 | 5 | 26949251 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.89e-04 | 220 | 45 | 4 | 35785414 | |
| Pubmed | 1.94e-04 | 16 | 45 | 2 | 19576224 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.30e-04 | 430 | 45 | 5 | 35044719 | |
| Pubmed | Neural Stem Cells Direct Axon Guidance via Their Radial Fiber Scaffold. | 2.47e-04 | 18 | 45 | 2 | 32707082 | |
| Pubmed | 2.50e-04 | 689 | 45 | 6 | 36543142 | ||
| Pubmed | Compensation by tumor suppressor genes during retinal development in mice and humans. | 2.76e-04 | 19 | 45 | 2 | 16672052 | |
| Pubmed | 2.76e-04 | 19 | 45 | 2 | 15741318 | ||
| Pubmed | 2.81e-04 | 244 | 45 | 4 | 29884807 | ||
| Pubmed | 2.88e-04 | 1006 | 45 | 7 | 15226823 | ||
| Interaction | ANKRD17 interactions | 9.20e-06 | 226 | 44 | 6 | int:ANKRD17 | |
| Interaction | HELZ interactions | 1.91e-05 | 257 | 44 | 6 | int:HELZ | |
| Interaction | CNOT8 interactions | 2.03e-05 | 74 | 44 | 4 | int:CNOT8 | |
| Interaction | DVL2 interactions | 2.39e-05 | 557 | 44 | 8 | int:DVL2 | |
| Interaction | CNOT2 interactions | 4.17e-05 | 178 | 44 | 5 | int:CNOT2 | |
| Interaction | SYNE3 interactions | 4.55e-05 | 444 | 44 | 7 | int:SYNE3 | |
| Interaction | NR2E1 interactions | 7.77e-05 | 38 | 44 | 3 | int:NR2E1 | |
| Interaction | TRIM66 interactions | 8.16e-05 | 205 | 44 | 5 | int:TRIM66 | |
| Interaction | RC3H1 interactions | 9.45e-05 | 677 | 44 | 8 | int:RC3H1 | |
| Interaction | CNOT11 interactions | 1.03e-04 | 112 | 44 | 4 | int:CNOT11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 6.86e-05 | 80 | 45 | 3 | chr5q32 | |
| Cytoband | 2p24.1 | 2.35e-04 | 23 | 45 | 2 | 2p24.1 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.06e-04 | 15 | 26 | 2 | 26 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.62e-03 | 53 | 26 | 2 | 532 | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 2.05e-05 | 160 | 45 | 4 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 2.05e-05 | 160 | 45 | 4 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.97e-05 | 176 | 45 | 4 | 67d6dc38708692f8c58cea5ed896f10718e9ffa6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.97e-05 | 176 | 45 | 4 | 125be81311f87563ca321472fcce6e0e0ae24c16 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.85e-05 | 188 | 45 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | severe_COVID-19-Plasmablast|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.93e-05 | 189 | 45 | 4 | 953143b2c2e87a4d8ef033a5fbb155fe62e9c78e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.18e-05 | 192 | 45 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.26e-05 | 193 | 45 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-05 | 194 | 45 | 4 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-05 | 194 | 45 | 4 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.62e-05 | 197 | 45 | 4 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 199 | 45 | 4 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.80e-05 | 199 | 45 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 200 | 45 | 4 | e5b4821fff40566c4a7dc3f74a14e27eb06b165d | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-04 | 128 | 45 | 3 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 3.42e-04 | 135 | 45 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.57e-04 | 137 | 45 | 3 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.56e-04 | 149 | 45 | 3 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-04 | 155 | 45 | 3 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-04 | 156 | 45 | 3 | 0de2fc695bd5f8d4633c514f71ea941c88137bac | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-04 | 156 | 45 | 3 | 4f92ca30755430db44402afc603d1ecd8bfc3617 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.41e-04 | 158 | 45 | 3 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 158 | 45 | 3 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.41e-04 | 158 | 45 | 3 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.41e-04 | 158 | 45 | 3 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 5.51e-04 | 159 | 45 | 3 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-04 | 159 | 45 | 3 | 1827493fb464bbddb2ee23f99472cfbcaf57405b | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-04 | 159 | 45 | 3 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.51e-04 | 159 | 45 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 160 | 45 | 3 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 160 | 45 | 3 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-04 | 162 | 45 | 3 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-04 | 162 | 45 | 3 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.82e-04 | 162 | 45 | 3 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-04 | 166 | 45 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.25e-04 | 166 | 45 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-04 | 166 | 45 | 3 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 6.25e-04 | 166 | 45 | 3 | 9788486582cc2c5f28b9ea015e235732f9fefb1e | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-04 | 166 | 45 | 3 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.36e-04 | 167 | 45 | 3 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.36e-04 | 167 | 45 | 3 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 6.36e-04 | 167 | 45 | 3 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-04 | 167 | 45 | 3 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-04 | 167 | 45 | 3 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 168 | 45 | 3 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.58e-04 | 169 | 45 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.58e-04 | 169 | 45 | 3 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.69e-04 | 170 | 45 | 3 | db0ec8b7ecbb4db108fc35c564df4b740f65cc8f | |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 6.69e-04 | 170 | 45 | 3 | fb05f49b7113470995b3c16683c54dc1a660b73a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.69e-04 | 170 | 45 | 3 | 88f6804e973863245ca1c7e5e6656d4a8b824da9 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.69e-04 | 170 | 45 | 3 | dad3aaf7d9f7bafdbddee51610f03f2359e587ae | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-04 | 171 | 45 | 3 | e59afa0a773dca3b9c208d17510ea55703b42598 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 175 | 45 | 3 | 97a58bc6ed2e8e359283d4214172c990c6e3755e | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.40e-04 | 176 | 45 | 3 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.52e-04 | 177 | 45 | 3 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | NS-critical-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.52e-04 | 177 | 45 | 3 | bbea488582f1eb863950c660afed9159630f6960 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass | 7.52e-04 | 177 | 45 | 3 | 37e03f51925345f5f716ef3abe1d2c4ccf129020 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.77e-04 | 179 | 45 | 3 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | NS-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.77e-04 | 179 | 45 | 3 | c044478525b8e7eedecddb924c1b049331180cb2 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-04 | 179 | 45 | 3 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.77e-04 | 179 | 45 | 3 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.77e-04 | 179 | 45 | 3 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 7.90e-04 | 180 | 45 | 3 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.90e-04 | 180 | 45 | 3 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-04 | 181 | 45 | 3 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.02e-04 | 181 | 45 | 3 | f7b08f662eb77ee7a777c6525ddc3195046aaf65 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.15e-04 | 182 | 45 | 3 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.15e-04 | 182 | 45 | 3 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.28e-04 | 183 | 45 | 3 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 8.28e-04 | 183 | 45 | 3 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.28e-04 | 183 | 45 | 3 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.42e-04 | 184 | 45 | 3 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-04 | 184 | 45 | 3 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-04 | 184 | 45 | 3 | fc708a5c8a7b19fab973c72dc4383a7d30f8b59a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.42e-04 | 184 | 45 | 3 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-04 | 184 | 45 | 3 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-04 | 184 | 45 | 3 | 14a5288d861260f63fbe0cbea3569cf643e7597e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.55e-04 | 185 | 45 | 3 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.55e-04 | 185 | 45 | 3 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.68e-04 | 186 | 45 | 3 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 8.68e-04 | 186 | 45 | 3 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 8.68e-04 | 186 | 45 | 3 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.68e-04 | 186 | 45 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.68e-04 | 186 | 45 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.82e-04 | 187 | 45 | 3 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.82e-04 | 187 | 45 | 3 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 8.82e-04 | 187 | 45 | 3 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | control-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.82e-04 | 187 | 45 | 3 | 94a44b31ce9fe6fb4758769018fb746e93c8f043 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 8.82e-04 | 187 | 45 | 3 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | mild_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 8.95e-04 | 188 | 45 | 3 | 9a5ba6abdc307402301dae25db2a5f3e0d576417 | |
| ToppCell | severe_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 8.95e-04 | 188 | 45 | 3 | 25ca19af4ac419a0f5026a6ccbd8b554b268a6f3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-04 | 188 | 45 | 3 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.95e-04 | 188 | 45 | 3 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.09e-04 | 189 | 45 | 3 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 9.09e-04 | 189 | 45 | 3 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 4.54e-05 | 7 | 44 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | self rated health | 9.83e-04 | 31 | 44 | 2 | EFO_0004778 | |
| Disease | language measurement | 1.06e-03 | 134 | 44 | 3 | EFO_0007797 | |
| Disease | chronotype measurement | 1.88e-03 | 882 | 44 | 6 | EFO_0008328 | |
| Disease | neuroimaging measurement | 4.85e-03 | 1069 | 44 | 6 | EFO_0004346 | |
| Disease | temporal horn of lateral ventricle volume measurement | 5.20e-03 | 72 | 44 | 2 | EFO_0010333 | |
| Disease | cortical thickness | 5.89e-03 | 1113 | 44 | 6 | EFO_0004840 | |
| Disease | parental longevity | 6.21e-03 | 494 | 44 | 4 | EFO_0007796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQQPPKGQAQASNGA | 141 | Q6IC98 | |
| QPQQSNAGVGQPASG | 1041 | Q68CP9 | |
| NGLAANNDSPGSGSQ | 176 | Q96DR7 | |
| KQSDGQTGSPQNSNS | 216 | Q76L83 | |
| NNGQNKSLAAAAPNG | 66 | Q9UKL0 | |
| NCGQVGSGSTANQPT | 156 | Q8NDN9 | |
| SPGGQQQKQGQSVTS | 811 | Q08999 | |
| SAISGQNNNHSGNKP | 41 | Q14244 | |
| ASRGQGQSQGQSQGP | 136 | Q9UQF2 | |
| QTNGSKGTAKAPQQG | 3841 | Q9UPA5 | |
| AQQAGPGKTSAQQTG | 451 | Q9Y6V0 | |
| QSAKSAAAGNQPGGN | 831 | P16499 | |
| SKGPQSSSGVNGNVQ | 296 | Q8IVL0 | |
| QPKKGQGTAATGNQA | 46 | Q5T1M5 | |
| QNQQSSGAAGPTGKN | 111 | O95232 | |
| GSGQQPQAGLSQANF | 266 | O75023 | |
| SSSGQGQQAQTQTGK | 311 | Q8N752 | |
| GNNNLGGSVSAPANS | 416 | Q7Z3U7 | |
| GTGSQAQPQPAANQA | 41 | Q14671 | |
| KQNSNSQSTPGSSGQ | 466 | A8CG34 | |
| PGGVSQGNSVNLKNS | 381 | Q9NYF0 | |
| TQNNGTLKGSNPSCQ | 1401 | Q96BY6 | |
| NQADLPSGNGNKSSG | 516 | O15063 | |
| TNSTQPNPKGSQGGN | 251 | Q9NRM1 | |
| GQRSGGGNKSNRSQN | 756 | Q9NR30 | |
| NKKPGQGTPNSANTQ | 121 | P08579 | |
| QGTPNSANTQGNSTP | 126 | P08579 | |
| KTNGNNGTNGALVQS | 16 | Q9HCJ0 | |
| PSNQSALGAGGANSN | 31 | Q9HCJ0 | |
| SSSGQGQQAQTPTGK | 311 | P48729 | |
| SSGQQGKPGSSSQQG | 206 | A0A1B0GUY1 | |
| SSQQGNLGTSGQQEK | 216 | A0A1B0GUY1 | |
| GNLHLSSQQGNQGPS | 256 | A0A1B0GUY1 | |
| NQSPVDQGATGASQG | 231 | P18827 | |
| ENSNNSQGPSQSGGT | 76 | P08047 | |
| NINKAQSNGSGNGSD | 1121 | Q9NRY4 | |
| IRPNGTSGNKHNNNG | 396 | Q8IYA6 | |
| QENGAKNSNQLGGNT | 481 | Q9H9A5 | |
| NNTKGNCGNIVQSNG | 1851 | O75443 | |
| NQQCNGSKGNGSNGS | 501 | O94967 | |
| DAQGQNDGNTGNQGK | 836 | Q7RTX0 | |
| KNGSSNTGAKQAGPQ | 561 | O95171 | |
| GGSGNDNNQAATKSP | 196 | Q9NS37 | |
| NNSNSGPNEIGNFGR | 936 | Q9HCK4 | |
| SNGNQPGGNSQGTAV | 151 | Q68DE3 | |
| GGSKGNKNGDNNSNH | 661 | Q9UGU0 | |
| SNSLNVNNGVPGGAA | 71 | Q9H7D7 | |
| VANQASSGAGGQPNI | 351 | O94842 | |
| NVAGRGNQQNGSPTD | 816 | Q9H0D2 |